IRONDisc Medicine, Inc.

$82.64

$55.9552 weeks$94.11

Price

$82.64+45%1Y

1M+8.8%1Y+45%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Average

5/10

Value44

Quality52

Momentum58

Growth-

Strongest Momentum, weakest Value · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

We are a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. We have assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.

In the company’s own words · 10-K filed Feb 26, 2026 · SEC EDGAR

P/E (TTM)-

Market Cap$2.70B

1Y Return+45%

5Y Return-34%